Osmotherapy in neurocritical care

被引:45
作者
Bhardwaj, Anish [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA
关键词
D O I
10.1007/s11910-007-0079-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Osmotherapy is the mainstay in the medical management of cerebral edema with or without elevations in intracranial pressure. Several osmotic agents have been utilized in clinical practice over the past five decades in a variety of brain injury paradigms. The over-riding premise for their beneficial effects has been via egress of water from the brain into the vascular compartment. In addition, many of these agents have beneficial extraosmotic properties that portend their use in cerebral resuscitation and treatment of cerebral edema. Although there is a paucity of large, randomized clinical trials that compare various osmotic agents, data are emerging from prospective clinical case series. This article provides a historical perspective of osmotherapy, examines characteristics of osmotic agents, and discusses caveats in their use in the clinical setting. Furthermore, this review highlights the utility of osmotic agents as tools to understand emerging mechanistic concepts in the evolution of brain edema, which are yielding important data of translational significance from laboratory-based research.
引用
收藏
页码:513 / 521
页数:9
相关论文
共 55 条
[1]   Aquaporin water channels - from atomic structure to clinical medicine [J].
Agre, P ;
King, LS ;
Yasui, M ;
Guggino, WB ;
Ottersen, OP ;
Fujiyoshi, Y ;
Engel, A ;
Nielsen, S .
JOURNAL OF PHYSIOLOGY-LONDON, 2002, 542 (01) :3-16
[2]   An α-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain [J].
Amiry-Moghaddam, M ;
Otsuka, T ;
Hurn, PD ;
Traystman, RJ ;
Haug, FM ;
Froehner, SC ;
Adams, ME ;
Neely, JD ;
Agre, P ;
Ottersen, OPT ;
Bhardwaj, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :2106-2111
[3]  
BENSTEN G, 2004, ACTA ANAESTH SCAND, V48, P1089
[4]   Mannitol use in acute stroke -: Case fatality at 30 days and 1 year [J].
Bereczki, D ;
Mihálka, L ;
Szatmári, S ;
Fekete, K ;
Di Cesar, D ;
Fülesdi, B ;
Csiba, L ;
Fekete, I .
STROKE, 2003, 34 (07) :1730-1735
[5]   Cerebral edema: Hypertonic saline solutions [J].
Anish Bhardwaj ;
John A. Ulatowski .
Current Treatment Options in Neurology, 1999, 1 (3) :179-187
[6]  
Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009
[7]   ORAL GLYCEROL FOR REDUCTION OF INTRACRANIAL PRESSURE [J].
CANTORE, G ;
VIRNO, M ;
GUIDETTI, B .
JOURNAL OF NEUROSURGERY, 1964, 21 (04) :278-&
[8]   QUANTITATIVE CT ASSESSMENT OF FUROSEMIDE-INDUCED AND MANNITOL-INDUCED CHANGES IN BRAIN WATER-CONTENT [J].
CASCINO, T ;
BAGLIVO, J ;
CONTI, J ;
SZEWCZYKOWSKI, J ;
POSNER, JB ;
ROTTENBERG, DA .
NEUROLOGY, 1983, 33 (07) :898-903
[9]   Plasma arginine-vasopressin following experimental stroke: effect of osmotherapy [J].
Chang, Y ;
Chen, TY ;
Chen, CH ;
Crain, BJ ;
Toung, TJK ;
Bhardwaj, A .
JOURNAL OF APPLIED PHYSIOLOGY, 2006, 100 (05) :1445-1451
[10]   FUROSEMIDE-INDUCED AND MANNITOL-INDUCED CHANGES IN INTRACRANIAL-PRESSURE AND SERUM OSMOLALITY AND ELECTROLYTES [J].
COTTRELL, JE ;
ROBUSTELLI, A ;
POST, K ;
TURNDORF, H .
ANESTHESIOLOGY, 1977, 47 (01) :28-30